How to Choose the Best Probiotic: Look Beyond Strains and CFU Count

To choose a probiotic, do not look only at the longest strain list or biggest CFU number. Check which strains are named, whether the CFU count applies at the end of shelf life, how the product is protected during storage, whether its delivery system has evidence for surviving stomach conditions, and where it releases. The delivered viable dose is the number that reaches the intestine alive - not only the number printed on the label.

When you compare probiotics, many packs can look impressive. One may have a long list of strains. Another may show a very large CFU count. A third may use a special capsule.

Strains and CFU count are important. But there is another question worth asking:

How many of those microorganisms are likely to reach the intestine alive?

What makes a probiotic a probiotic?

A probiotic is a live microorganism that provides a health benefit when taken in an adequate amount. [1-2]

The word live matters. Being alive is not an optional extra. It is part of what makes a microorganism a probiotic.

This is why viability matters. Viability simply means whether the microorganisms are still alive.

Why are strains and CFU count only part of the picture?

The strain name identifies the microorganism in the product. Strain identity is an important part of comparing probiotics.

The CFU count also matters. CFU means colony-forming units. It is a way of estimating how many bacteria in a product are able to grow.

But these details do not answer every question. A label may show how many organisms are in the product, yet it may not show how many will survive storage and digestion.

Think of the strains as the passengers and the delivery system as the vehicle. Choosing the right passengers matters. But the vehicle must also help them reach their destination.

What can stop probiotics from reaching the intestine alive?

Probiotic organisms face challenges both before and after you swallow them. [3]

Before the probiotic is swallowed

Probiotics must stay stable during manufacturing, transport and storage. Several things may reduce the number that remain alive:

• Oxygen: Some probiotic organisms are sensitive to air.
• Moisture: Humidity may activate dormant organisms too early and reduce their survival.
• Heat: High temperatures or changing temperatures may damage them.
• Light: Long exposure to light may also lower survival in some strains.

This means the probiotic’s journey starts long before it reaches your mouth.

After the probiotic is swallowed

The digestive tract creates another set of challenges:

• Stomach acid: The stomach is strongly acidic, usually around pH 1.5 to 3.5.
• Digestive enzymes: These help break down food but may also damage bacterial cells.
• Bile salts: These help digest fat but may harm bacterial membranes.
• Time in the digestive tract: The journey exposes organisms to several stresses in a row.

Some microorganisms may survive these conditions better than others. Product design may also affect how well they are protected.

Why can the label dose differ from the delivered dose?

The CFU number on the label is not always the same as the number delivered to the intestine alive. [3]

The cited research gives a simple example using a starting dose of 10 billion CFU:

• No loss: 10 billion remain
• One-log loss: 1 billion remain
• Two-log loss: 100 million remain
• Three-log loss: 10 million remain
• Four-log loss: 1 million remain

A “log loss” is a way scientists describe a large drop in bacterial numbers. You do not need to understand the maths to see the main point: a small change in survival can create a very large change in the final number.

This example does not mean every probiotic will lose the same amount. It shows why two products with similar label claims may deliver very different viable doses.

Storage stability, sensitivity to oxygen, stomach survival, bile tolerance and delivery technology may all play a part.

What should a probiotic delivery system do?

No delivery system can remove every challenge. A well-designed system should aim to:

• Protect the microorganisms during manufacturing and storage
• Limit exposure to oxygen and moisture
• Reduce early exposure to stomach acid
• Support survival through the upper digestive tract
• Release viable organisms closer to their intended destination
• Preserve enough live organisms to support their intended function

A delayed-release capsule is designed to release its contents later in the digestive tract rather than opening immediately in the stomach.

This does not mean every delayed-release product works in the same way. The exact design and the evidence supporting it still matter.

What does the research say about delayed-release capsules?

In one laboratory study, researchers used the SHIME® system. This is a controlled model that copies important parts of human digestion.

It is an in vitro study. This means the test was done in a laboratory model rather than as a study of health outcomes in people.

Researchers compared four probiotic formats:

• A liquid formulation
• A powder formulation
• A conventional capsule
• A delayed-release capsule

The delayed-release formulation kept about half of the probiotic population alive through simulated upper digestive transit.

Depending on the test used, it showed:

• 51.7 ± 10.4% viability or survival
• 56.0 ± 15.4% ability to grow under laboratory conditions

In the liquid, powder and conventional-capsule formulations tested, survival and ability to grow were each below 1%. [4]These results suggest that delivery format can affect how many organisms survive. However, they apply to the specific formulations tested.

They do not prove that every delayed-release capsule is better than every powder, liquid or standard capsule.

Important: This was a laboratory simulation. It studied survival and delivery, not health improvements in people.

The same laboratory work found that surviving organisms still affected fermentation in a simulated colon. This suggests that they remained active after the simulated digestive journey.

However, this was mechanistic evidence. It was not proof of a health benefit in people. [4]

Does it matter where a probiotic capsule opens?

Release location may matter when a product is intended to reach a later part of the digestive tract.

A human imaging study used MRI and tracer methods to see when and where different capsule combinations opened. The study included six healthy volunteers. Its purpose was not to find out whether the capsules improved health. [5]

One capsule-in-capsule design, called DRcaps® within DRcaps®, had the lowest variation among the combinations tested. It consistently opened only after reaching the ileum.

The ileum is the last part of the small intestine before the colon.

Opening there may:

• Reduce early exposure to stomach conditions
• Delay release until later in the digestive journey
• Increase the chance of delivering the contents to a later part of the intestine

The finding shows that capsule design can change release location. It does not show that later release will always lead to a better health result.

Important: The study measured capsule opening and release location. It did not measure probiotic effectiveness or health outcomes.

How do you compare probiotics? A simple checklist

Use these questions when comparing products:

1. Are the strains clearly identified? Look for clear strain information on the product or supporting material.
2. Are the claims supported by relevant evidence? Check whether the company explains what evidence supports its claims.
3. Is the CFU count stated at the end of shelf life? This may be more useful than a count stated only when the product was made.
4. How is the product protected during storage? Look for information about moisture, oxygen, heat and storage stability.
5. Is there evidence for survival through stomach conditions? Do not assume a large label count means the same number reaches the intestine.
6. Does the product use a specific delivery system? Find out what the system is designed to do and whether it has been studied.
7. Has the release location been investigated? A capsule designed for later release should have evidence showing when or where it opens.
8. Does the product include a prebiotic substrate? A prebiotic is a substance that selected microorganisms can use. It may help support microbial activity after delivery.
9. Is the type of evidence explained clearly? Laboratory survival results are not the same as proof of better symptoms or health outcomes in people.

These questions come from the product-evaluation framework in the cited research.

Choosing a probiotic: the bottom line

The best probiotic cannot be judged by one large number on the front of the pack.

Strain identity matters. CFU count matters. But stability, survival, delivery technology and release location may matter too.

The key question is not only:

“How many organisms were put into the product?”

It is also:

“How many are likely to remain alive when they reach the intestine?”

A careful choice looks at the whole formulation. It considers what is inside, how it is protected, where it is released and what type of evidence supports those claims.

Choosing a probiotic frequently asked questions

Is a higher CFU count always better?

The available research does not set one ideal CFU count for every person or product. A high starting number may be less useful if many organisms are lost during storage or digestion. Compare the CFU count with evidence on stability, survival and delivery rather than judging the product by the biggest number alone.

Do probiotics survive stomach acid?

Some probiotic organisms may survive stomach acid, but survival can vary. The stomach is a major barrier because its strong acid can damage microorganisms. The organism and the product’s design may both affect survival. Evidence from a specific formulation is more useful than assuming all probiotics behave in the same way.

Are probiotic capsules better than powders or liquids?

Not always. In one laboratory simulation, the delayed-release capsule tested had much higher survival than the liquid, powder and conventional-capsule formulations tested. This does not prove that every capsule is better than every powder or liquid. Results depend on the exact formulation and the evidence behind it.

What is a delayed-release probiotic capsule?

A delayed-release capsule is designed to open later in the digestive tract instead of releasing its contents immediately in the stomach. The aim is to reduce early exposure to stomach conditions and help more live organisms reach a later part of the digestive tract.

Why does capsule release location matter?

Release location matters because opening later may reduce exposure to harsh stomach conditions. In one human MRI study, a capsule-in-capsule design consistently opened after reaching the ileum. The study showed that capsule design can change where release happens, but it did not prove better health outcomes.

What should I look for on a probiotic label?

Look for clearly identified strains, a CFU count stated at the end of shelf life, storage guidance and information about delivery technology. Also check whether survival and release claims are backed by relevant evidence. Be cautious when laboratory findings are presented as proof of health benefits in people.

Related choosing a probiotic reading

• Do probiotics survive stomach acid?
• Do probiotics need refrigeration?
• Explore DuoCap delivery

Choosing a probiotic references

1. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-514.
2. FAO/WHO. Guidelines for the Evaluation of Probiotics in Food. London (ON): FAO/WHO Working Group Report; 2002.
3. Cook MT, Tzortzis G, Charalampopoulos D, Khutoryanskiy VV. Microencapsulation and oral delivery of probiotics. Int J Pharm. 2012;436(1-2):1-10.
4. Govaert M, Rotsaert C, Vannieuwenhuyse C, Duysburgh C, Medlin S, Marzorati M, Jarrett H. Survival of Probiotic Bacterial Cells in the Upper Gastrointestinal Tract and the Effect of the Surviving Population on the Colonic Microbial Community Activity and Composition. Nutrients. 2024 Aug 21;16(16):2791. doi: 10.3390/nu16162791. PMID: 39203927; PMCID: PMC11357584.
5. Rump A, Weiss FN, Schulz L, Meister R, Kohnhorst C, Hensel A. The Effect of Capsule-in-Capsule Combinations on In Vivo Disintegration in Human Volunteers: A Combined Imaging and Salivary Tracer Study. Pharmaceutics. 2021;13(12):2002. doi:10.3390/pharmaceutics13122002.

Choosing a probiotic evidence note

The survival, fermentation and microbial activity findings discussed in this article provide mechanistic evidence. They should not be viewed as direct proof of clinical benefit. This article is for general education and does not diagnose, treat, prevent or cure disease.